Pradžia › Rabdoidas
Rabdoidas klinikiniai tyrimai JAV ieško dalyvių
17 tyrimai dėl Rabdoidas ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Washington, DC5 tyrimai
- Houston, TX4 tyrimai
- Mountain View, CA3 tyrimai
- St. Louis, MO3 tyrimai
- Birmingham, AL3 tyrimai
Pagal valstiją
- Alabama3 tyrimai
- Kalifornija4 tyrimai
- Kolumbijos apskritis5 tyrimai
- Misūris3 tyrimai
- Tennessee3 tyrimai
- Texas6 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Renkami dalyviai1 fazė
Amžius nuo 1 iki 30 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07087002NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
Renkami dalyviai1 fazė
Amžius nuo 3 iki 25 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07664176HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Renkami dalyviai1 fazė
36 Months – 22 Years · Visoms lytims · Atnaujinta 2026-09-04 · NCT03911388B7-H3.CD28Z.CART in CNS Neoplasms
Renkami dalyviai1 fazė
Amžius nuo 2 iki 21 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07390539Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Renkami dalyviai1/2 fazė
Iki 26 metų · Visoms lytims · Atnaujinta 2026-09-03 · NCT06465199Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Renkami dalyviai1 fazė
Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2026-08-06 · NCT04715191C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Renkami dalyviai1 fazė
12 Months – 25 Years · Visoms lytims · Atnaujinta 2026-08-03 · NCT04099797Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Renkami dalyviai1/2 fazė
6 Months – 25 Years · Visoms lytims · Atnaujinta 2026-06-30 · NCT06625190Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
Renkami dalyviai2 fazė
Amžius nuo 1 iki 39 · Visoms lytims · Atnaujinta 2026-06-23 · NCT07447076Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Renkami dalyviai1 fazė
Amžius nuo 1 iki 30 · Visoms lytims · Atnaujinta 2026-06-17 · NCT06193759B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Renkami dalyviai1 fazė
Iki 21 metų · Visoms lytims · Atnaujinta 2026-05-19 · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Renkami dalyviai1/2 fazė
12 Months – 30 Years · Visoms lytims · Atnaujinta 2026-05-19 · NCT04901702A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Renkami dalyviai2 fazė
12 Months · Visoms lytims · Atnaujinta 2026-05-06 · NCT05985161Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Renkami dalyviai1 fazė
Amžius nuo 1 iki 26 · Visoms lytims · Atnaujinta 2026-04-13 · NCT04185038Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Renkami dalyviai1 fazė
Amžius nuo 1 iki 26 · Visoms lytims · Atnaujinta 2026-02-17 · NCT07148050Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Renkami dalyviai1 fazė
Iki 21 metų · Visoms lytims · Atnaujinta 2025-11-03 · NCT06198296A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Renkami dalyviai2 fazė
18 Months – 40 Years · Visoms lytims · Atnaujinta 2025-08-12 · NCT05135975Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.